Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases

BACKGROUND: Bedaquiline was recently introduced into World Health Organization (WHO)-recommended regimens for treatment of drug resistant tuberculosis. There is limited data on the long-term safety of bedaquiline. Because bedaquiline prolongs the QT interval, there are concerns regarding cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Jackie, Mudaly, Vanessa, Voget, Jacqueline, Naledi, Tracey, Maartens, Gary, Cohen, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585062/
https://www.ncbi.nlm.nih.gov/pubmed/31221100
http://dx.doi.org/10.1186/s12879-019-4197-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585062/
https://www.ncbi.nlm.nih.gov/pubmed/31221100
http://dx.doi.org/10.1186/s12879-019-4197-7

Ejemplares similares